FDA Approved Products

Application #	Type	Sponsor	Product #	Drug Name	Form	Strength	Active Ingredient	Approval Date	Marketing Status	Reference Standard
761359	BLA	TAKEDA PHARMS USA	001	ENTYVIO	INJECTABLE;INTRAVENOUS	300MG	VEDOLIZUMAB	2024-04-18	Prescription	No
761359	BLA	TAKEDA PHARMS USA	002	ENTYVIO	INJECTABLE;SUBCUTANEOUS	108MG/0.68ML	VEDOLIZUMAB	2024-04-18	Prescription	No
213976	NDA	TAKEDA PHARMS USA	001	EOHILIA	SUSPENSION;ORAL	2MG/10ML	BUDESONIDE	2024-02-09	Prescription	Yes
217564	NDA	TAKEDA PHARMS USA	001	FRUZAQLA	CAPSULE;ORAL	1MG	FRUQUINTINIB	2023-11-08	Prescription	No
217564	NDA	TAKEDA PHARMS USA	002	FRUZAQLA	CAPSULE;ORAL	5MG	FRUQUINTINIB	2023-11-08	Prescription	Yes
761133	BLA	TAKEDA PHARMS USA	001	ENTYVIO	INJECTABLE;INTRAVENOUS	300MG	VEDOLIZUMAB	2023-09-27	Prescription	No
761133	BLA	TAKEDA PHARMS USA	002	ENTYVIO	INJECTABLE;INJECTION	108MG/0.68ML	VEDOLIZUMAB	2023-09-27	Prescription	No
215596	NDA	TAKEDA PHARMS USA	001	LIVTENCITY	TABLET;ORAL	200MG	MARIBAVIR	2021-11-23	Prescription	Yes
215310	NDA	TAKEDA PHARMS USA	001	EXKIVITY	CAPSULE;ORAL	EQ 40MG BASE	MOBOCERTINIB SUCCINATE	2021-09-15	Discontinued	No
210166	NDA	TAKEDA PHARMS USA	001	MOTEGRITY	TABLET;ORAL	EQ 1MG BASE	PRUCALOPRIDE SUCCINATE	2018-12-14	Prescription	No
210166	NDA	TAKEDA PHARMS USA	002	MOTEGRITY	TABLET;ORAL	EQ 2MG BASE	PRUCALOPRIDE SUCCINATE	2018-12-14	Prescription	Yes
022063	NDA	TAKEDA PHARMS USA	001	MYDAYIS	CAPSULE, EXTENDED RELEASE;ORAL	3.125MG;3.125MG;3.125MG;3.125MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2017-06-20	Prescription	No
			002	MYDAYIS	CAPSULE, EXTENDED RELEASE;ORAL	6.25MG;6.25MG;6.25MG;6.25MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2017-06-20	Prescription	No
			003	MYDAYIS	CAPSULE, EXTENDED RELEASE;ORAL	9.375MG;9.375MG;9.375MG;9.375MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2017-06-20	Prescription	No
			004	MYDAYIS	CAPSULE, EXTENDED RELEASE;ORAL	12.5MG;12.5MG;12.5MG;12.5MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2017-06-20	Prescription	Yes
208772	NDA	TAKEDA PHARMS USA	001	ALUNBRIG	TABLET;ORAL	30MG	BRIGATINIB	2017-04-28	Prescription	No
			002	ALUNBRIG	TABLET;ORAL	90MG	BRIGATINIB	2017-04-28	Prescription	No
			003	ALUNBRIG	TABLET;ORAL	180MG	BRIGATINIB	2017-04-28	Prescription	Yes
208510	NDA	TAKEDA PHARMS USA	001	VYVANSE	TABLET, CHEWABLE;ORAL	10MG	LISDEXAMFETAMINE DIMESYLATE	2017-01-28	Prescription	No
			002	VYVANSE	TABLET, CHEWABLE;ORAL	20MG	LISDEXAMFETAMINE DIMESYLATE	2017-01-28	Prescription	No
			003	VYVANSE	TABLET, CHEWABLE;ORAL	30MG	LISDEXAMFETAMINE DIMESYLATE	2017-01-28	Prescription	No
			004	VYVANSE	TABLET, CHEWABLE;ORAL	40MG	LISDEXAMFETAMINE DIMESYLATE	2017-01-28	Prescription	No
			005	VYVANSE	TABLET, CHEWABLE;ORAL	50MG	LISDEXAMFETAMINE DIMESYLATE	2017-01-28	Prescription	No
			006	VYVANSE	TABLET, CHEWABLE;ORAL	60MG	LISDEXAMFETAMINE DIMESYLATE	2017-01-28	Prescription	Yes
208056	NDA	TAKEDA PHARMS USA	001	DEXILANT SOLUTAB	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	30MG	DEXLANSOPRAZOLE	2016-01-26	Discontinued	No
208462	NDA	TAKEDA PHARMS USA	001	NINLARO	CAPSULE;ORAL	EQ 2.3MG BASE	IXAZOMIB CITRATE	2015-11-20	Prescription	No
			002	NINLARO	CAPSULE;ORAL	EQ 3MG BASE	IXAZOMIB CITRATE	2015-11-20	Prescription	No
			003	NINLARO	CAPSULE;ORAL	EQ 4MG BASE	IXAZOMIB CITRATE	2015-11-20	Prescription	Yes
204734	NDA	TAKEDA PHARMS USA	001	FOSRENOL	POWDER;ORAL	EQ 750MG BASE	LANTHANUM CARBONATE	2014-09-24	Prescription	No
204734	NDA	TAKEDA PHARMS USA	002	FOSRENOL	POWDER;ORAL	EQ 1GM BASE	LANTHANUM CARBONATE	2014-09-24	Prescription	Yes
125476	BLA	TAKEDA PHARMS USA	001	ENTYVIO	INJECTABLE;INJECTION	300MG	VEDOLIZUMAB	2014-05-20	Prescription	No
204447	NDA	TAKEDA PHARMS USA	001	TRINTELLIX	TABLET;ORAL	EQ 5MG BASE	VORTIOXETINE HYDROBROMIDE	2013-09-30	Prescription	No
			002	TRINTELLIX	TABLET;ORAL	EQ 10MG BASE	VORTIOXETINE HYDROBROMIDE	2013-09-30	Prescription	No
			003	TRINTELLIX	TABLET;ORAL	EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	VORTIOXETINE HYDROBROMIDE	2013-09-30	Discontinued	No
			004	TRINTELLIX	TABLET;ORAL	EQ 20MG BASE	VORTIOXETINE HYDROBROMIDE	2013-09-30	Prescription	Yes
203414	NDA	TAKEDA PHARMS USA	001	KAZANO	TABLET;ORAL	EQ 12.5MG BASE;500MG	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	2013-01-25	Prescription	No
203414	NDA	TAKEDA PHARMS USA	002	KAZANO	TABLET;ORAL	EQ 12.5MG BASE;1GM	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	2013-01-25	Prescription	Yes
022271	NDA	TAKEDA PHARMS USA	001	NESINA	TABLET;ORAL	EQ 6.25MG BASE	ALOGLIPTIN BENZOATE	2013-01-25	Prescription	No
			002	NESINA	TABLET;ORAL	EQ 12.5MG BASE	ALOGLIPTIN BENZOATE	2013-01-25	Prescription	No
			003	NESINA	TABLET;ORAL	EQ 25MG BASE	ALOGLIPTIN BENZOATE	2013-01-25	Prescription	Yes
022426	NDA	TAKEDA PHARMS USA	001	OSENI	TABLET;ORAL	EQ 25MG BASE;EQ 15MG BASE	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	2013-01-25	Prescription	No
			002	OSENI	TABLET;ORAL	EQ 25MG BASE;EQ 30MG BASE	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	2013-01-25	Prescription	No
			003	OSENI	TABLET;ORAL	EQ 25MG BASE;EQ 45MG BASE	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	2013-01-25	Prescription	Yes
			004	OSENI	TABLET;ORAL	EQ 12.5MG BASE;EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	2013-01-25	Discontinued	No
			005	OSENI	TABLET;ORAL	EQ 12.5MG BASE;EQ 30MG BASE	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	2013-01-25	Prescription	No
			006	OSENI	TABLET;ORAL	EQ 12.5MG BASE;EQ 45MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	2013-01-25	Discontinued	No
203441	NDA	TAKEDA PHARMS USA	001	GATTEX KIT	POWDER;SUBCUTANEOUS	5MG/VIAL	TEDUGLUTIDE	2012-12-21	Prescription	Yes
203469	NDA	TAKEDA PHARMS USA	001	ICLUSIG	TABLET;ORAL	EQ 15MG BASE	PONATINIB HYDROCHLORIDE	2012-12-14	Prescription	No
			002	ICLUSIG	TABLET;ORAL	EQ 45MG BASE	PONATINIB HYDROCHLORIDE	2012-12-14	Prescription	Yes
			003	ICLUSIG	TABLET;ORAL	EQ 30MG BASE	PONATINIB HYDROCHLORIDE	2012-12-14	Prescription	No
			004	ICLUSIG	TABLET;ORAL	EQ 10MG BASE	PONATINIB HYDROCHLORIDE	2012-12-14	Prescription	No
202799	NDA	TAKEDA PHARMS USA	007	OMONTYS	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 10MG BASE/ML (EQ 10MG BASE/ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			008	OMONTYS	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 20MG BASE/2ML (EQ 10MG BASE/ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			001	OMONTYS PRESERVATIVE FREE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			002	OMONTYS PRESERVATIVE FREE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			003	OMONTYS PRESERVATIVE FREE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			004	OMONTYS PRESERVATIVE FREE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			005	OMONTYS PRESERVATIVE FREE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
			006	OMONTYS PRESERVATIVE FREE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML)	PEGINESATIDE ACETATE	2012-03-27	Discontinued	No
022150	NDA	TAKEDA PHARMS USA	001	FIRAZYR	INJECTABLE;SUBCUTANEOUS	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	ICATIBANT ACETATE	2011-08-25	Prescription	Yes
022037	NDA	TAKEDA PHARMS USA	001	INTUNIV	TABLET, EXTENDED RELEASE;ORAL	EQ 1MG BASE	GUANFACINE HYDROCHLORIDE	2009-09-02	Prescription	No
			002	INTUNIV	TABLET, EXTENDED RELEASE;ORAL	EQ 2MG BASE	GUANFACINE HYDROCHLORIDE	2009-09-02	Prescription	No
			003	INTUNIV	TABLET, EXTENDED RELEASE;ORAL	EQ 3MG BASE	GUANFACINE HYDROCHLORIDE	2009-09-02	Prescription	No
			004	INTUNIV	TABLET, EXTENDED RELEASE;ORAL	EQ 4MG BASE	GUANFACINE HYDROCHLORIDE	2009-09-02	Prescription	Yes
022352	NDA	TAKEDA PHARMS USA	001	COLCRYS	TABLET;ORAL	0.6MG	COLCHICINE	2009-07-29	Discontinued	No
022024	NDA	TAKEDA PHARMS USA	001	ACTOPLUS MET XR	TABLET, EXTENDED RELEASE;ORAL	1GM;EQ 15MG BASE	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	2009-05-12	Discontinued	No
022024	NDA	TAKEDA PHARMS USA	002	ACTOPLUS MET XR	TABLET, EXTENDED RELEASE;ORAL	1GM;EQ 30MG BASE	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	2009-05-12	Discontinued	No
021856	NDA	TAKEDA PHARMS USA	001	ULORIC	TABLET;ORAL	40MG	FEBUXOSTAT	2009-02-13	Prescription	No
021856	NDA	TAKEDA PHARMS USA	002	ULORIC	TABLET;ORAL	80MG	FEBUXOSTAT	2009-02-13	Prescription	Yes
022287	NDA	TAKEDA PHARMS USA	001	DEXILANT	CAPSULE, DELAYED RELEASE;ORAL	30MG	DEXLANSOPRAZOLE	2009-01-30	Prescription	No
022287	NDA	TAKEDA PHARMS USA	002	DEXILANT	CAPSULE, DELAYED RELEASE;ORAL	60MG	DEXLANSOPRAZOLE	2009-01-30	Prescription	Yes
021977	NDA	TAKEDA PHARMS USA	001	VYVANSE	CAPSULE;ORAL	30MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	No
			002	VYVANSE	CAPSULE;ORAL	50MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	No
			003	VYVANSE	CAPSULE;ORAL	70MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	Yes
			004	VYVANSE	CAPSULE;ORAL	20MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	No
			005	VYVANSE	CAPSULE;ORAL	40MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	No
			006	VYVANSE	CAPSULE;ORAL	60MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	No
			007	VYVANSE	CAPSULE;ORAL	10MG	LISDEXAMFETAMINE DIMESYLATE	2007-02-23	Prescription	No
022000	NDA	TAKEDA PHARMS USA	001	LIALDA	TABLET, DELAYED RELEASE;ORAL	1.2GM	MESALAMINE	2007-01-16	Prescription	Yes
021925	NDA	TAKEDA PHARMS USA	001	DUETACT	TABLET;ORAL	2MG;30MG	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	2006-07-28	Prescription	Yes
021925	NDA	TAKEDA PHARMS USA	002	DUETACT	TABLET;ORAL	4MG;30MG	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	2006-07-28	Prescription	No
021842	NDA	TAKEDA PHARMS USA	001	ACTOPLUS MET	TABLET;ORAL	500MG;EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	2005-08-29	Discontinued	No
021842	NDA	TAKEDA PHARMS USA	002	ACTOPLUS MET	TABLET;ORAL	850MG;EQ 15MG BASE	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	2005-08-29	Prescription	Yes
021782	NDA	TAKEDA PHARMS USA	001	ROZEREM	TABLET;ORAL	8MG	RAMELTEON	2005-07-22	Prescription	Yes
021468	NDA	TAKEDA PHARMS USA	001	FOSRENOL	TABLET, CHEWABLE;ORAL	EQ 250MG BASE	LANTHANUM CARBONATE	2004-10-26	Discontinued	No
			002	FOSRENOL	TABLET, CHEWABLE;ORAL	EQ 500MG BASE	LANTHANUM CARBONATE	2004-10-26	Prescription	No
			003	FOSRENOL	TABLET, CHEWABLE;ORAL	EQ 750MG BASE	LANTHANUM CARBONATE	2004-10-26	Prescription	No
			004	FOSRENOL	TABLET, CHEWABLE;ORAL	EQ 1GM BASE	LANTHANUM CARBONATE	2004-10-26	Prescription	Yes
021602	NDA	TAKEDA PHARMS USA	001	VELCADE	INJECTABLE;INTRAVENOUS, SUBCUTANEOUS	3.5MG/VIAL	BORTEZOMIB	2003-05-13	Prescription	Yes
021428	NDA	TAKEDA PHARMS USA	001	PREVACID	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	15MG	LANSOPRAZOLE	2002-08-30	Prescription	No
021428	NDA	TAKEDA PHARMS USA	002	PREVACID	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	30MG	LANSOPRAZOLE	2002-08-30	Prescription	Yes
021303	NDA	TAKEDA PHARMS USA	001	ADDERALL XR 10	CAPSULE, EXTENDED RELEASE;ORAL	2.5MG;2.5MG;2.5MG;2.5MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2001-10-11	Prescription	No
			006	ADDERALL XR 15	CAPSULE, EXTENDED RELEASE;ORAL	3.75MG;3.75MG;3.75MG;3.75MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2001-10-11	Prescription	No
			002	ADDERALL XR 20	CAPSULE, EXTENDED RELEASE;ORAL	5MG;5MG;5MG;5MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2001-10-11	Prescription	No
			004	ADDERALL XR 25	CAPSULE, EXTENDED RELEASE;ORAL	6.25MG;6.25MG;6.25MG;6.25MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2001-10-11	Prescription	No
			003	ADDERALL XR 30	CAPSULE, EXTENDED RELEASE;ORAL	7.5MG;7.5MG;7.5MG;7.5MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2001-10-11	Prescription	Yes
			005	ADDERALL XR 5	CAPSULE, EXTENDED RELEASE;ORAL	1.25MG;1.25MG;1.25MG;1.25MG	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2001-10-11	Prescription	No
021073	NDA	TAKEDA PHARMS USA	001	ACTOS	TABLET;ORAL	EQ 15MG BASE	PIOGLITAZONE HYDROCHLORIDE	1999-07-15	Prescription	No
			002	ACTOS	TABLET;ORAL	EQ 30MG BASE	PIOGLITAZONE HYDROCHLORIDE	1999-07-15	Prescription	No
			003	ACTOS	TABLET;ORAL	EQ 45MG BASE	PIOGLITAZONE HYDROCHLORIDE	1999-07-15	Prescription	Yes
050757	NDA	TAKEDA PHARMS USA	001	PREVPAC (COPACKAGED)	CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL	500MG;500MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE	1997-12-02	Discontinued	No
020712	NDA	TAKEDA PHARMS USA	001	CARBATROL	CAPSULE, EXTENDED RELEASE;ORAL	200MG	CARBAMAZEPINE	1997-09-30	Prescription	No
			002	CARBATROL	CAPSULE, EXTENDED RELEASE;ORAL	300MG	CARBAMAZEPINE	1997-09-30	Prescription	Yes
			003	CARBATROL	CAPSULE, EXTENDED RELEASE;ORAL	100MG	CARBAMAZEPINE	1997-09-30	Prescription	No
020333	NDA	TAKEDA PHARMS USA	001	AGRYLIN	CAPSULE;ORAL	EQ 0.5MG BASE	ANAGRELIDE HYDROCHLORIDE	1997-03-14	Prescription	No
020333	NDA	TAKEDA PHARMS USA	002	AGRYLIN	CAPSULE;ORAL	EQ 1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANAGRELIDE HYDROCHLORIDE	1997-03-14	Discontinued	No
019815	NDA	TAKEDA PHARMS USA	001	PROAMATINE	TABLET;ORAL	2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	MIDODRINE HYDROCHLORIDE	1996-09-06	Discontinued	No
			002	PROAMATINE	TABLET;ORAL	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	MIDODRINE HYDROCHLORIDE	1996-09-06	Discontinued	No
			003	PROAMATINE	TABLET;ORAL	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	MIDODRINE HYDROCHLORIDE	1996-09-06	Discontinued	No
020406	NDA	TAKEDA PHARMS USA	001	PREVACID	CAPSULE, DELAYED REL PELLETS;ORAL	15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	LANSOPRAZOLE	1995-05-10	Discontinued	No
020406	NDA	TAKEDA PHARMS USA	002	PREVACID	CAPSULE, DELAYED REL PELLETS;ORAL	30MG	LANSOPRAZOLE	1995-05-10	Prescription	Yes
020049	NDA	TAKEDA PHARMS USA	001	PENTASA	CAPSULE, EXTENDED RELEASE;ORAL	250MG	MESALAMINE	1993-05-10	Prescription	No
020049	NDA	TAKEDA PHARMS USA	002	PENTASA	CAPSULE, EXTENDED RELEASE;ORAL	500MG	MESALAMINE	1993-05-10	Prescription	Yes
050601	NDA	TAKEDA	001	CERADON	INJECTABLE;INJECTION	EQ 1GM BASE/VIAL	CEFOTIAM HYDROCHLORIDE	1988-12-30	Discontinued	No